---
title: "QuidelOrtho FY26 Q2 GAAP net loss narrows to $93 million; revenue rises 3% to $631 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295140087.md"
description: "QuidelOrtho reported a narrowed GAAP net loss of $93 million for FY26 Q2, with revenue rising 3% to $631 million. However, the company lowered its full-year revenue and adjusted EBITDA forecasts due to China IVD pricing changes and a softer global respiratory environment, while withdrawing free cash flow guidance."
datetime: "2026-08-06T20:29:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295140087.md)
  - [en](https://longbridge.com/en/news/295140087.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295140087.md)
generator: "portal-rs"
---

# QuidelOrtho FY26 Q2 GAAP net loss narrows to $93 million; revenue rises 3% to $631 million

-   QuidelOrtho posted a GAAP net loss of USD 93 million, narrowing from a GAAP net loss of USD 255 million a year earlier. \* GAAP diluted loss per share narrowed to USD 1.36 from USD 3.77; adjusted diluted EPS was USD 0.13. \* Revenue rose 3% to USD 631 million, led by Point of Care up 16% to USD 108 million. \* Management cited China IVD pricing changes and a softer global respiratory environment; updated 2026 revenue view cut to USD 2.52-USD 2.60 billion. \* Adjusted EBITDA forecast reduced to USD 540-USD 560 million; free cash flow guidance was withdrawn. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quidelortho Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608061605PR\_NEWS\_USPR\_\_\_\_\_LA20543) on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [QDEL.US](https://longbridge.com/en/quote/QDEL.US.md)

## Related News & Research

- [Aptorum Group GAAP EPS of -$1.60](https://longbridge.com/en/news/296654186.md)
- [XORTX Therapeutics Inc. GAAP EPS of -$1.05](https://longbridge.com/en/news/296650983.md)
- [Cathay Capital-backed cpap.com forms joint venture with AdaptHealth for direct-to-consumer sleep apnea brands](https://longbridge.com/en/news/296110892.md)
- [NovaBridge net loss widens to $37.9 million in FY26 first half; R&D expenses more than doubled to $14.3 million](https://longbridge.com/en/news/296478660.md)
- [Vivos Opens New Henderson Sleep Testing and Treatment Center](https://longbridge.com/en/news/296656579.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**